1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Mycosis Fungoides Market
2.2. Global Mycosis Fungoides Market, By Treatment, 2023 (US$ Million)
2.3. Global Mycosis Fungoides Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Mycosis Fungoides Market: Competitive Analysis
3.1. Market Positioning of Key Mycosis Fungoides Market Vendors
3.2. Strategies Adopted by Mycosis Fungoides Market Vendors
3.3. Key Industry Strategies
4. Mycosis Fungoides Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Mycosis Fungoides Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Topical Steroids
5.3.2. Mechlorethamine Gel
5.3.3. HDAC Inhibitors
5.3.4. Monoclonal Antibodies
5.3.5. Localized Radiation Therapy
5.3.6. Extracorporeal Photopheresis
5.3.7. Others


6. North America Mycosis Fungoides Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
6.3.Mycosis Fungoides Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)

7. UK and European Union Mycosis Fungoides Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
7.3.Mycosis Fungoides Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)

8. Asia Pacific Mycosis Fungoides Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
8.3.Mycosis Fungoides Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)

9. Latin America Mycosis Fungoides Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
9.3.Mycosis Fungoides Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)

10. Middle East and Africa Mycosis Fungoides Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
10.3.Mycosis Fungoides Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Mycosis Fungoides Market: By Treatment, 2022-2032, USD (Million)

11. Company Profile
11.1. Astellas Pharma
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Bayer AG
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Dover Medical and Scientific Equipment, Ltd.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Elorac, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Kyowa Kirin, Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Macopharma
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Sanofi SA
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Soligenix, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Varian Medical Systems
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Yaupon Therapeutics
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives